{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:14:21Z","timestamp":1764260061793,"version":"3.44.0"},"reference-count":10,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2018,12,18]]},"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Autoimmune myelofibrosis is a distinct clinicopathological entity that occurs with autoimmune disorders. We report the case of a 44-year-old woman admitted with pancytopenia and clinical features of systemic lupus erythematosus, Sjogren\u2019s syndrome and antiphospholipid antibodies syndrome. Bone marrow biopsy showed decreased global cells and an increase of reticulin fibres on argentic coloration, consistent with myelofibrosis. The JAK2 V617, Myeloproliferative leukemia (MPL) and calreticulin mutations were negative. The patient\u2019s condition improved after treatment with hydroxychloroquine, vitamin K antagonists and prednisone.<\/jats:p>","DOI":"10.1136\/bcr-2018-227520","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T12:56:05Z","timestamp":1547470565000},"page":"bcr-2018-227520","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Autoimmune myelofibrosis: a rare haematological involvement in systemic lupus erythematosus"],"prefix":"10.1136","volume":"12","author":[{"given":"Nabil","family":"Belfeki","sequence":"first","affiliation":[{"name":"Internal Medicine and Infectious Disease Department, Centre Hospitalier Sud Ile de France, Melun, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinath","family":"Shankarasivam","sequence":"additional","affiliation":[{"name":"Internal Medicine and Infectious Disease Department, Centre Hospitalier Sud Ile de France, Melun, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damienne","family":"Declerck","sequence":"additional","affiliation":[{"name":"Pathological Laboratory, Laboratoire d\u2019anatomopathologie d\u2019Avon, Avon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Diamantis","sequence":"additional","affiliation":[{"name":"Internal Medicine and Infectious Disease Department, Centre Hospitalier Sud Ile de France, Melun, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"2025082801410700000_12.1.bcr-2018-227520.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2025082801410700000_12.1.bcr-2018-227520.2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10258"},{"key":"2025082801410700000_12.1.bcr-2018-227520.3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/0961203316657434","article-title":"Incidence of systemic lupus erythematosus in a population-based cohort using revised 1997 American College of Rheumatology and the 2012 Systemic Lupus International Collaborating Clinics classification criteria","volume":"26","author":"Ungprasert","year":"2017","journal-title":"Lupus"},{"key":"2025082801410700000_12.1.bcr-2018-227520.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"2025082801410700000_12.1.bcr-2018-227520.5","first-page":"9","article-title":"American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: A consensus and data driven methodology involving three international patient cohorts","volume":"2017","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025082801410700000_12.1.bcr-2018-227520.6","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-349","article-title":"Bone marrow fibrosis as a feature of systemic lupus erythematosus: a case report and literature review","volume":"3","author":"Chalayer","year":"2014","journal-title":"Springerplus"},{"key":"2025082801410700000_12.1.bcr-2018-227520.7","doi-asserted-by":"publisher","DOI":"10.3109\/10428190009113399"},{"key":"2025082801410700000_12.1.bcr-2018-227520.8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/ajh.24592","article-title":"Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management","volume":"91","author":"Tefferi","year":"2016","journal-title":"Am J Hematol"},{"key":"2025082801410700000_12.1.bcr-2018-227520.9","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199405000-00003"},{"key":"2025082801410700000_12.1.bcr-2018-227520.10","first-page":"58","article-title":"Systemic lupus erythematosus and myelofibrosis: A case report and revision of literature","volume":"9","author":"Del Porto","year":"2018","journal-title":"Leuk Res Rep"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-227520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:41:13Z","timestamp":1756370473000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-227520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,14]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1136\/bcr-2018-227520"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-227520","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}